News Archives - Page 52 of 94

WednesdayMay 10, 2023 2:37 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Reports New TSU Contract, Renewal by Longtime Client; Announces Town Hall Meeting

Knightscope (NASDAQ: KSCP) is maintaining its momentum as a leading developer of autonomous security robots (“ASR”) and blue light emergency communication systems. The company continues to see contracts — both new and renewals — as it works to make the United States the safest country in the world. The company’s most recent renewal is with a well-known media and entertainment company. The client, which first signed with Knightscope seven years ago to patrol one of its North Hollywood properties, has renewed its contract for 24/7/365 ASR surveillance. In addition, Knightscope announced that Texas State University (“TSU”) has inked a deal with Knightscope…

WednesdayMay 10, 2023 2:17 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Results of 2023 Annual Meeting

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the results of the 2023 Annual Meeting. According to the update, the company held the meeting at 1:00 p.m. PT on May 9, 2023, whereby there were 3,372,024 shares of the company represented in person or by proxy, constituting 56.3% of the company's issued share capital as of the meeting date of March 13, 2023. The matters voted upon and the final voting results are set forth as detailed in the announcement. All proposals are described in detail in Lexaria’s proxy statement filed with the Securities…

WednesdayMay 10, 2023 1:11 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Announces Q1 2023 Results, to Host Live Call and Webcast

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced business updates and financial results for the first quarter ended March 31, 2023. Among the business highlights, Cepton reported OEM series production execution and that it is on-track to receive final production validation for salable vehicles and continue to ship pre-production lidar units for multiple vehicle models. In addition, Cepton has completed final implementation of embedded software, including cybersecurity, over-the-air updates, functional safety and multiple custom features for OEMs. As detailed in the announcement, the company will host a live conference call and webcast to…

TuesdayMay 09, 2023 3:46 pm

TinyGemsBreaks — Cepton Inc. (NASDAQ: CPTN), NVIDIA Collaborating to Integrate Leading Lidar Tech into Driving Simulation Platform

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is collaborating with NVIDIA to incorporate its Vista-X120 Plus lidar into DRIVE Sim, an end-to-end simulation platform built on Omniverse. The company noted that the announcement builds on previous integrations of its automotive lidar models that were used for the development of autonomous driving algorithms, sensors and software. In fact, the announcement noted that Cepton was one of the first lidar companies to showcase a 360-degree-coverage, dual-range lidar simulation; this tech was key in developing near-range blind spot elimination and long-range obstacle detection. The collaboration involves Cepton providing simulated sensor…

TuesdayMay 09, 2023 2:26 pm

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Doses Last Subject in Phase 1, Part B CYB004-E Trial

Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, has completed dosing in part b of its three-part CYB004-E phase 1 trial. The study is designed to evaluate intravenous N,N-dimethyltryptamine (“IV DMT”) in healthy volunteers. The company also announced that it now plans to move forward with part C of the study, which involves the first-in-human dosing of its proprietary DMT molecule CYB004 and will evaluate IV bolus + infusion regimens of CYB004 in a crossover design. The company expects that findings from both parts of the…

MondayMay 08, 2023 3:01 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Dosing Completed on Human Clinical Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has completed dosing for 36 subjects in its human clinical oral nicotine study: NIC-H22-1. According to the announcement, the study is the result of the focus Lexaria has had for years on oral nicotine formulations as an alternative to vaping or smoking; the company noted that results from the study could lead to more rapid commercial adoption and distribution of its patented DehydraTECH(TM) absorption technology, which is designed to improve oral uptake. Statistics show that some 7 million people die every year from cigarette smoking, and alternatives for nicotine delivery…

MondayMay 08, 2023 2:00 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Discontinues Alliance with Mexico-Based Freight Company

Freight Technologies (NASDAQ: FRGT), a technology company whose custom-developed Fr8App offers a real-time portal for business-to-business (“B2B”) cross-border shipping and domestic shipping within the USMCA region, has discontinued its alliance with Zaro Transportation. Fr8App is an industry-leading freight-matching platform powered by AI and machine-learning. “At Fr8Tech, we entered into the strategic alliance with Zaro expecting to be able to reach a certain level of sales at margins that we expected would be lower than our other business segments but at acceptable levels,” said Fr8App CEO Javier Selgas in the press release. “Our alliance with Zaro enhanced Zaro’s ability to provide…

MondayMay 08, 2023 1:56 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Board Appointment of Pharma and Biotech Industry Veteran Dr. Bettina M. Cockroft

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced its appointment of Bettina M. Cockroft, M.D., M.B.A., to its board of directors. Dr. Cockroft, a well-established industry executive with over 30 years of experience in the biopharmaceutical industry with clinical development expertise across multiple therapeutic areas, will serve as an independent director. “On behalf of the CNS Pharmaceuticals board and management, we are thrilled to welcome Dr. Cockroft to the board. Her appointment adds deep scientific, clinical and operational expertise, and…

MondayMay 08, 2023 11:47 am

TinyGemsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Releases Q1 2023 Financial, Corporate Report, Announces Earnings Call

Energy Fuels (NYSE American: UUUU) (TSX: EFR) is reporting on its financial results for the quarter ended March 31, 2023; the company also announced that it will host an earning conference call and webcast on May 9, 2023. According to the report, Energy Fuels sold 300,000 pounds of uranium resulting in a gross margin of 58% and 79,344 pounds of vanadium totaling a 37% gross margin of 37%; the company also sold its Alta Mesa property for a total gain of $116.45 million. The report showed that UUUU’s working capital grew with total assets increasing and total liabilities decreasing. Other highlights…

FridayMay 05, 2023 1:17 pm

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Subsidiary Inks Stiff Person Syndrome Clinical Trial Agreement with Mayo Clinic

Aditxt (NASDAQ: ADTX), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, and its subsidiary Adimune(TM) Inc. announced a clinical trial agreement with Mayo Clinic. The clinical trial, which is designed to advance clinical studies targeting autoimmune diseases of the central nervous system (“CNS”), is expected to begin this year with an estimated 10 to 15 patients, some of whom may also suffer from type-1 diabetes; the initial focus of the study will be on the autoimmune disease Stiff Person Syndrome (“SPS”). According to the announcement, Adimune, which was created to lead Aditxt’s immune…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: News